BioNTech Stock Options

BNTX Stock  USD 99.27  0.31  0.31%   
BioNTech's latest option contracts expiring on June 20th 2025 are carrying combined implied volatility of 0.57 with a put-to-call open interest ratio of 0.8 over 66 outstanding agreements suggesting investors are buying slightly more calls than puts on contracts expiring on June 20th 2025. The total put volume is at 1.0, with calls trading at the volume of 27.0. This yields a 0.04 put-to-call volume ratio.

Open Interest Against June 20th 2025 Option Contracts

BioNTech option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in BioNTech's lending market. For example, when BioNTech's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on BioNTech, he or she must hedge the risk by shorting BioNTech stock over its option's life.
The chart above shows BioNTech's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. BioNTech's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for BioNTech's option, there is no secondary market available for investors to trade.

BioNTech Maximum Pain Price Across 2025-06-20 Option Contracts

Max pain occurs when BioNTech's market makers reach a net positive position across all BioNTech's options at a strike price where option holders stand to lose the most money. By contrast, BioNTech's option sellers may reap the most after selling more options than buying, causing them to expire worthless.

In The Money vs. Out of Money Option Contracts on BioNTech

Analyzing BioNTech's in-the-money options over time can help investors to take a profitable long position in BioNTech regardless of its overall volatility. This is especially true when BioNTech's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money BioNTech's options could be used as guardians of the underlying stock as they move almost dollar for dollar with BioNTech's stock while costing only a fraction of its price.

BioNTech SE In The Money Call Balance

When BioNTech's strike price is surpassing the current stock price, the option contract against BioNTech SE stock is said to be in the money. When it comes to buying BioNTech's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on BioNTech SE are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

BioNTech Current Options Market Mood

BioNTech's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps BioNTech Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most BioNTech's options investors are not very successful. BioNTech's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current BioNTech contract

Base on the Rule 16, the options market is currently suggesting that BioNTech SE will have an average daily up or down price movement of about 0.0356% per day over the life of the 2025-06-20 option contract. With BioNTech trading at USD 99.27, that is roughly USD 0.0354. If you think that the market is fully incorporating BioNTech's daily price movement you should consider buying BioNTech SE options at the current volatility level of 0.57%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing BioNTech options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" BioNTech calls. Remember, the seller must deliver BioNTech SE stock to the call owner when a call is exercised.

BioNTech Option Chain

When BioNTech's strike price is surpassing the current stock price, the option contract against BioNTech SE stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
BioNTech's option chain is a display of a range of information that helps investors for ways to trade options on BioNTech. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for BioNTech. It also shows strike prices and maturity days for a BioNTech against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
BNTX250620C00185000158185.00.0 - 2.50.7Out
Call
BNTX250620C0018000010180.00.0 - 2.50.46Out
Call
BNTX250620C001750003175.00.0 - 2.51.3Out
Call
BNTX250620C00170000164170.00.0 - 2.552.37Out
Call
BNTX250620C0016500058165.00.0 - 2.64.3Out
Call
BNTX250620C001600001243160.00.0 - 2.652.16Out
Call
BNTX250620C00155000221155.00.0 - 2.70.6Out
Call
BNTX250620C00150000329150.00.15 - 2.81.1Out
Call
BNTX250620C00145000316145.00.75 - 0.950.95Out
Call
BNTX250620C00140000482140.00.0 - 3.21.4Out
Call
BNTX250620C00135000165135.00.9 - 2.71.4Out
Call
BNTX250620C00130000332130.01.25 - 2.62.02Out
Call
BNTX250620C00125000823125.01.95 - 2.852.3Out
Call
BNTX250620C00120000144120.01.1 - 3.93.6Out
Call
BNTX250620C00115000198115.03.4 - 5.14.96Out
Call
BNTX250620C00110000149110.03.5 - 6.06.35Out
Call
BNTX250620C00105000152105.06.4 - 8.48.41Out
Call
BNTX250620C00100000101100.08.4 - 10.610.05Out
Call
BNTX250620C00097500897.59.2 - 11.822.73In
Call
BNTX250620C0009500029095.09.8 - 13.024.0In
Call
BNTX250620C000925001692.511.7 - 14.429.48In
Call
BNTX250620C0009000025790.012.8 - 15.828.9In
Call
BNTX250620C00087500587.514.5 - 17.710.4In
Call
BNTX250620C00085000585.016.3 - 19.623.3In
Call
BNTX250620C00082500182.518.1 - 21.126.43In
Call
BNTX250620C00080000180.020.0 - 23.444.87In
Call
BNTX250620C00075000875.024.2 - 27.439.2In
Call
BNTX250620C00072500172.526.5 - 29.649.1In
Call
BNTX250620C000700001070.028.7 - 31.944.7In
Call
BNTX250620C000600001260.037.5 - 42.454.5In
 Put
BNTX250620P001850000185.084.0 - 88.184.0In
 Put
BNTX250620P001800000180.079.3 - 83.179.3In
 Put
BNTX250620P001750000175.074.7 - 78.074.7In
 Put
BNTX250620P001700000170.068.7 - 73.568.7In
 Put
BNTX250620P001650000165.063.6 - 68.563.6In
 Put
BNTX250620P001600000160.058.7 - 63.558.7In
 Put
BNTX250620P001550000155.053.7 - 58.553.7In
 Put
BNTX250620P001500001150.048.8 - 53.543.72In
 Put
BNTX250620P001450001145.043.7 - 48.526.8In
 Put
BNTX250620P001400000140.040.0 - 43.240.0In
 Put
BNTX250620P001350004135.034.8 - 38.535.1In
 Put
BNTX250620P0013000074130.030.4 - 34.016.5In
 Put
BNTX250620P00125000305125.026.2 - 29.415.2In
 Put
BNTX250620P0012000046120.021.8 - 24.422.68In
 Put
BNTX250620P00115000173115.018.0 - 20.319.1In
 Put
BNTX250620P00110000202110.014.7 - 16.913.91In
 Put
BNTX250620P0010500055105.010.0 - 13.612.4In
 Put
BNTX250620P0010000099100.07.7 - 10.78.52In
 Put
BNTX250620P0009750010597.56.2 - 9.37.6Out
 Put
BNTX250620P0009500037095.04.8 - 8.17.16Out
 Put
BNTX250620P000925006392.54.9 - 7.05.0Out
 Put
BNTX250620P0009000063290.03.8 - 5.04.75Out
 Put
BNTX250620P0008750056987.51.95 - 5.14.25Out
 Put
BNTX250620P0008500041385.01.25 - 5.33.8Out
 Put
BNTX250620P000825005882.50.8 - 3.53.0Out
 Put
BNTX250620P0008000011780.00.15 - 4.02.58Out
 Put
BNTX250620P0007750061977.50.25 - 3.71.88Out
 Put
BNTX250620P0007500013875.00.0 - 3.41.49Out
 Put
BNTX250620P00072500272.50.0 - 3.10.38Out
 Put
BNTX250620P0007000020370.00.0 - 2.850.51Out
 Put
BNTX250620P000650008965.00.0 - 1.250.05Out
 Put
BNTX250620P0006000011260.00.0 - 2.350.36Out
 Put
BNTX250620P00055000255.00.0 - 2.21.55Out
 Put
BNTX250620P000500002350.00.0 - 2.150.2Out
 Put
BNTX250620P00047500347.50.0 - 2.150.18Out
 Put
BNTX250620P000450007045.00.0 - 2.150.5Out

BioNTech Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

BioNTech Total Stockholder Equity

Total Stockholder Equity

20.38 Billion

At this time, BioNTech's Total Stockholder Equity is fairly stable compared to the past year.

BioNTech Corporate Management

Katalin KarikoSenior TherapiesProfile
Jens HolsteinCFO BoardProfile
Annemarie HanekampChief BoardProfile
Sylke MaasVice StrategyProfile
Michael BoehlerMD CommunicationsProfile
Siegbert KloosDatand DigitalProfile
Beate BernsSenior ResourcesProfile

Additional Tools for BioNTech Stock Analysis

When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.